"
Team:Montreal/Project
From 2008.igem.org
(→Cloning Plan) |
(→Cloning Plan) |
||
| Line 18: | Line 18: | ||
===Cloning Plan=== | ===Cloning Plan=== | ||
| - | ''Plasmid<sub>A</sub>'': λcI + TetR + LacI (Elowitz Repressilator) | + | '''Plasmid<sub>A</sub>''': λcI + TetR + LacI (Elowitz Repressilator) |
* Sent/extracted from Dr. Michael Elowitz (Caltech). | * Sent/extracted from Dr. Michael Elowitz (Caltech). | ||
| - | ''Plasmid<sub>B</sub>'': I<sub>14001</sub> + J<sub>40001</sub> + TetR/YFP (Elowitz Reporter) + kan<sup>+</sup> | + | '''Plasmid<sub>B</sub>''': I<sub>14001</sub> + J<sub>40001</sub> + TetR/YFP (Elowitz Reporter) + kan<sup>+</sup> |
1. Cut J-brick genes out of plasmid with XbaI/SpeI | 1. Cut J-brick genes out of plasmid with XbaI/SpeI | ||
Revision as of 20:53, 20 June 2008
| Home | The Team | The Project | Parts Submitted to the Registry | Modeling | Notebook |
|---|
Contents |
Experimental
To create our functional bacteria, we intend to transform a line of MC4100 E. coli cells used by Elowitz with two plasmids. The first plasmid will contain the Repressilator (λcI, TetR and LacI), described in his 2000 paper. The second plasmid will be a triple-ligation of the I14001 bio-brick, the J40001 bio-brick and the Elowitz reporter (TetR, YFP).
If successful, we intend to observe and experiment with our cells with fluorescence microscopy and spectrophotometry. Using three individual filters, we can microscopically observe the oscillations of individual components by the three fluorescent proteins (ECFP, GFP and RFP) embedded in the system.
Project Objectives
Cloning Plan
PlasmidA: λcI + TetR + LacI (Elowitz Repressilator)
- Sent/extracted from Dr. Michael Elowitz (Caltech).
PlasmidB: I14001 + J40001 + TetR/YFP (Elowitz Reporter) + kan+
1. Cut J-brick genes out of plasmid with XbaI/SpeI
2. Ligate to J-brick genes to I-brick plasmid cut with XbaI (+dephosphorylation)
3. Select on amp+/kan+ plates (I-brick plasmid carries resistance for both ampicillin and kanomycin)
4. Cut of I and J-brick genes with EcoRI
5. Ligate genes to Elowitz reporter plasmid cut with EcoRI (3-way ligation)
6. Select on kan+ LB plates
Future Applications
Pacemaking Technology
Once of the better known sinusoidal oscillators in the human body are the cells of the sinoatrial node of the heart that establish a regular rhythm of action potentials that propagate throughout the atria and ventricles to generate beats. While current artificial pacemakers focus primarily on re-establishing this rhythm by generating electrical potentials, a biological alternative could prove more effective and less invasive than its mechanical counterpart with further research.
Continuous Cultures in Industrial Bio-Reactors
A common problem in bio-reactors used by pharmaceutical and biotechnology companies results from difficulties in growing cells in continuous cultures due to various complications in recycling nutrients and draining metabolites. An effectively oscillating system could reduce the reliance on current fed-batch systems by allowing more effective cycles of cell growth and protein expression.
Biological Drug Delivery
With biological alternatives now being increasingly explored as mechanisms of delivering therapeutics, a functionally oscillating system could prove invaluable to tailoring drug regimes to specific systems. Innumerable biological processes function in rhythmic on/off switches and being able to control the release of certain cellular components to such a schedule may permit more effective treatment.•
